A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer - Chan, J S; Beer, T M; Quinn, D I; Pinski, J K; Garzotto, M; Sokoloff, M; Dehaze, D R; Ryan, C W (BJU Int, 2008)